Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (161-170 of 743) with videos related to

Pageof 75
Sort By:
Melanoma Research|April 15, 2017
Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case reportCarla Murer, Pascale Kränzlin-Stieger, Lars E French, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in MelanomaAndrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|November 10, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous MelanomaAndreas Dzung, Annalisa Saltari, Natascia Tiso, et al.
Melanoma Research|March 15, 2019
Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanomaJoanna Mangana, Florentia Dimitriou, Ralph Braun, et al.
JAAD Case Reports|August 30, 2021
Acute progression of the leukemic phase in mycosis fungoides and Sézary syndromeHasina Maredia, Antonio Cozzio, Reinhard Dummer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Immune activation status of CD8+ T cells infiltrating non-small cell lung cancerAndreas Trojan, Mirjana Urosevic, Reinhard Dummer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 26, 2022
Adult xanthogranuloma with LMNA-NTRK1 gene fusion - a possible driver of proliferationMelike Ak, Egle Ramelyte, Laurence Imhof, et al.
International Journal of Cancer|July 15, 2004
Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patientsReinhard Dummer, Abraham Mittelman, Francesco P Fanizzi, et al.
Dermatology (Basel, Switzerland)|June 19, 2024
Post-Excision Soft X-Ray Radiotherapy for Keloids: Experience in a Tertiary Referral CenterEgle Ramelyte, Michèle Welti, Fabian Gardin, et al.
The Lancet. Oncology|December 4, 2018
Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?Jean Jacques Grob, Claus Garbe, Paolo Ascierto, et al.
Pageof 75

Showing results (161-170 of 743) with videos related to

Sort By:
Pageof 75
Melanoma Research|April 15, 2017
Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case reportCarla Murer, Pascale Kränzlin-Stieger, Lars E French, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in MelanomaAndrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|November 10, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous MelanomaAndreas Dzung, Annalisa Saltari, Natascia Tiso, et al.
Melanoma Research|March 15, 2019
Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanomaJoanna Mangana, Florentia Dimitriou, Ralph Braun, et al.
JAAD Case Reports|August 30, 2021
Acute progression of the leukemic phase in mycosis fungoides and Sézary syndromeHasina Maredia, Antonio Cozzio, Reinhard Dummer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Immune activation status of CD8+ T cells infiltrating non-small cell lung cancerAndreas Trojan, Mirjana Urosevic, Reinhard Dummer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 26, 2022
Adult xanthogranuloma with LMNA-NTRK1 gene fusion - a possible driver of proliferationMelike Ak, Egle Ramelyte, Laurence Imhof, et al.
International Journal of Cancer|July 15, 2004
Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patientsReinhard Dummer, Abraham Mittelman, Francesco P Fanizzi, et al.
Dermatology (Basel, Switzerland)|June 19, 2024
Post-Excision Soft X-Ray Radiotherapy for Keloids: Experience in a Tertiary Referral CenterEgle Ramelyte, Michèle Welti, Fabian Gardin, et al.
The Lancet. Oncology|December 4, 2018
Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?Jean Jacques Grob, Claus Garbe, Paolo Ascierto, et al.
Pageof 75